Optimization of Colorimetric Loop-Mediated Isothermal Amplification for the Diagnosis of Human Cytomegalovirus in Kidney Transplant Patients

 

Théophile Uwiringiyeyezu1,2*, Bouchra El Khalfi1, Jamal Belhachmi2 and Abdelaziz Soukri1*

1Laboratory of Physiopathology, Molecular Genetics and Biotechnology, Aïn Chock Faculty of Sciences, Biology and Health Research Center; Hassan II University of Casablanca, Morocco

2Laboratoire Al Kindy of Medicals Analysis, Casablanca, Morocco

*For correspondence: tuwiringiyeyezu19904@gmail.com

Received 14 September 2022; Accepted 31 December 2022; Published 27 January 2023

 

Abstract

 

Human Cytomegalovirus infection is one of the acute risk factors for rejection after kidney transplantation. qPCR used for detection is an expensive method, so, molecular biology rapid diagnosis technique is essential to determine the viral load and initiate early treatment to avoid graft rejection. We therefore proposed to develop a colorimetric CMVLAMP technique by using WarmStart Colorimetric LAMP 2X Master mix; this method has the advantages of being fast, reliable, very sensitive and cost-effective. The results of the present study demonstrated that the developed method has high specificity to HCMV DNA, not cross-reacting with viruses with genetic similarity to HCMV such as herpes simplex virus type HSV1-2, varicella zoster virus, Epstein Barr Virus, this method was sensitive to viral load > 150 copies/mL as the results of qPCR the reference method. The sensitivity of this method was 100%, the specificity 100%. In conclusion, in the present study, we developed the colorimetric CMVLAMP method that is revealed to be sensitive, specific, rapid cheap and, the coloration indicator simplifies the pathogen detection, thus, in transplant patients, this method presents an economical alternative in medical diagnosis. © 2023 Friends Science Publishers

 

Keywords: Kidney transplant recipients; Molecular biology; PCR; Colorimetric CMVLAMP; Human cytomegalovirus; Medical diagnosis; WarmStart Colorimetric LAMP2X Master Mix; Bromophenol Blue

 


Introduction

 

Human cytomegalovirus is ubiquitous opportunistic adenovirus that is widespread throughout the world with a high prevalence of 60-80% (Griffiths and Reeves 2021). Diagnosing this virus is difficult because of its genetic similarity to other herpesviruses such as Hespes Simplex Virus (HSV1-2), Epstein Barr Virus (EBV) or Varicella Zoster Virus (VZV) (Hollier and Grissom 2005). This viral infection also stays unremarked without clinical symptoms in people with robust immunity, therefore, the clinical symptoms are often noticed in newborns because of congenital infection (Demmler-Harrison et al. 2020; Uchida et al. 2020) in patients with chronic diseases such as diabetes (Uchida et al. 2020), Hepatitis C (Khalil et al. 2022), tuberculosis (Olbrich et al. 2021), HIV (Pang et al. 2020) and in transplant patients treated with immunosuppressant’s (Rump et al. 2020). To diagnose the serology of this virus, medical analysis laboratories have different reagents available on the market that use principles such as chemioluminescence (Dourado Junior et al. 2021), immunofluorescence (Faure-Bardon et al. 2021), or western blot (Zheng et al. 2020). The treatment and follow-up of a patient infected with human cytomegalovirus is conditioned by the quantification of the viral load by the PCR method, which remains the standard method for detecting this virus, but the cost of the analysis remains expensive and sometimes less sensitive at very low viral load, and trained professionals are needed for this method (Uwiringiyeyezu et al. 2019, 2022).

Various studies that have been conducted to develop other PCR-derived methods to facilitate the accessibility. The LAMP is the one of the developed methods and has many advantages. These include the use of isothermal conditions and detection by colorimetric change to reveal positivity or negativity (Notomi et al. 2000; Nagamine et al. 2001; Suzuki et al. 2006, 2010). The consequences of HCMV infection, which belongs to the Herpesviridae family, are accompanied by chronic graft rejection if HCMV is not diagnosed before in the donor and graft recipient. This virus is also known to have a latent phase and can reactivate later as a result of weakening of the body's immunity and still have several consequences (Heald-Sargent et al. 2020). Research has shown a relation between active HCMV infection in transplant patients and graft rejection (Rump et al. 2020). The risk of viral infection is higher in transplant patients due to the use of immunosuppressive drugs such as tacrolimus or cyclosporine (Rump et al. 2020; Winstead et al. 2021) and leads to disruption to the graft function and rejection, which can be chronic (Rump et al. 2020; Winstead et al. 2021; Da Cunha and Wu 2021).

Seroconversion can be used to detect anti-HCMV antibodies in transplant patients (Zheng et al. 2020; Dourado Junior et al. 2021; Faure-Bardon et al. 2021), however, it is rarely effective, especially when the transplant donor has latent HCMV which would allow seronegativity to be concerned patient. Detection of virus genome by quantitative polymerase chain reaction (qPCR) has become an important laboratory tool for the diagnosis and treatment of this viral infection (Uwiringiyeyezu et al. 2019, 2022). Many other previous studies have reported qPCR for the detection and quantification of HCMV in various biological fluid samples. LAMPPCR is a new and evolving nucleic acid amplification method and has been recommended for the detection of HCMV viral genomic DNA. This method has been used for the rapid diagnosis of a numerous infectious diseases including herpes viruses (Miyachi et al. 2021), Epstein-Barr virus (Nie et al. 2008), hepatitis B virus (Cai et al. 2008) and CMV (Wang et al. 2015; Uwiringiyeyezu et al. 2019, 2022). The LAMP method is capable of amplifying specific DNA sequences under isothermal conditions and requires relatively simple and inexpensive equipment, making it suitable for use in all diagnostic and research laboratories.

As outlined in Fig. 1, our objective was to develop and evaluate a CMVLAMP method for the colorimetric detection of HCMV DNA in plasma of kidney transplant patients. This method is a potential alternative for screening and monitoring HCMV infection.

 

Materials and Methods

 

Clinical samples and HCMV DNA extraction

 

Whole blood samples from 135 transplant patients who were registered at AL KINDY Medical Analysis Laboratory (Casablanca, Morocco) were selected since 2017 and used in the present study. The study was conducted by comparing HCMV positivity and negativity of CMVLAMP and real-time qPCR method. Patient consent was obtained, and the study was authorized by the Human Research Ethics Committee of Hassan II University in Casablanca. The samples were first centrifuged at 4000 rpm for 10 min. The obtained plasma was used for nucleic acid extraction with the EZ1 DSP Virus kit on the EZ1 Advanced XL (Qiagen GmbH, Hilden, Germany), according to the manufacturer’s instructions. Extracted DNA was eluted into 60 µL of elution buffer and stored at -20oC before being used for the following steps. One part of total extracted DNA was quantified by optical density (OD) measurements at 260 nm using a spectrophotometer (Nanodrop lite; Thermo Fisher Scientific, Wilmington, DE, USA) and the other was used for real-time PCR amplification using the Artus-CMV-QS-RGQ kit (Qiagen GmbH, Hilden, Germany), the other for CMVLAMP isothermal amplification. Other samples positive for herpes simplex virus HSV (1-2), varicella zoster virus (VZV), Epstein Barr virus (EBV), BKV were extracted with the same kits to evaluate the specificity of our method.

 

Primer design for LAMP

 

The primers for CMVLAMP amplification in this study target the glycoprotein B (gB) gene from data obtained from the GenBank virus genome (accession number: M60931) https://www.ncbi.nlm.nih.gov/nuccore/M60931.1/ (Wang et al. 2015). The Oligonucleotide primers used in the present study were designed using Primer Explorer V5 software (Eiken Chemical Co. Ltd., Tokyo, Japan) http://primerexplorer.jp/e/ (Notomi et al. 2000), Primers designers http://www.premierbiosoft.com/isothermal/lamp. html and Biolabs software (New England Biolabs, Beverly, MA) https://lamp.neb.com/#!/. The designed primer sequences were verified with BLAST (https://blast.ncbi.nlm.nih.gov/Blast.cgi De La Fuente et al. 2018) to exclude any possibility of cross-reaction with herpes simplex virus HSV (1-2), varicella zoster virus (VZV), Epstein Barr Virus (EBV) or BKV. Primers consisted of two outer primers (F3/B3) and two inner primers (FIP)/ (BIP) and 2 additional loop primers (LF/LB). Details of the sequence and location of each nucleotide primer in the target DNA sequences are provided in Table 1.

 

LAMP reaction with WarmStart colorimetric LAMP 2X master mix

 

Colorimetric CMVLAMP reaction is performed using WarmStart Colorimetric LAMP 2X Master Mix (New England Biolabs, Inc., Ipswich, MA, USA). The protocol is available on the link https://international.neb.com/protocols/ 2016/08/15/warmstart-colorimetric-lamp-2x-master-mix-typical-lamp-protocol-m1800 (Rubinfien et al. 2020). In a 25 µL mixture, 12.5 µL of WarmStart Colorimetric LAMP 2X Master Mix, 2.5 µL of primer mix, 5 µL of DNA and 5 µL of molecular biology grade water were used. The mixture was incubated at 65°C in a water bath for 30 min, the positive samples changed color from purple to yellow and the negative samples remained purple.

 

LAMP reaction with thermopol buffer

 

This reaction was conducted with 10x Thermopol buffer (New England Biolabs, Inc., Ipswich, MA, USA) which is a buffer composed of 20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4, 0.1% Triton® X-100, pH 8.8@25°C The LAMP reaction was performed according to the protocol available on the link:

 

Fig. 1: Experimental design that it illustrates all the stages we have used from the start to the end of our research study

 

Table 1: Primers targeting glycoprotein B, gB of human cytomegalovirus (HCMV)

 

Primers 

Primers sequences

Mm (g/mol)

Tm

Qty (µg)

CMVgB-LB

5’-GCCCTACCTCAAGGGTCTGGA-3’

6407.2

53.1°C

409

CMVgB-LF

5’-GAAGGTGGCAACGCCTTCG-3’

5853.9

62.0°C

395

CMVgB-BIP

5’- CGCCCAGGCCGCTCATGAGGTTTTTAAGGTAGTCGACCCGCTACC-3’

13773.9

69.5°C

936

CMVgB-FIB

5’- AGCCATTGGGGCCGTGGGTGTTTTACGCTCCGAAGGGGTTTTTG-3’

13672.9

67.9 °C

222

CMVgB-B3

5’- AAGCAGCGGGTAAAGTAC-5’

5581.7

54.0°C

360

CMVgB-F3

5’- GGCTATGGCCACGAGGAT-3’

5564.7

58.0°C

149

-----81170

----AGTGATAATGACTACGGCTATGGCCACGAGGATGATGGTG A ACGCTCCGA AGGGGTTTTTG AGGAAGGTG

                                                              F3                                                                               F2

GCAACGCCTTCGA CCACGGA GGC CACCGCG CCACCCACGG CCCCAATGGCT ACGCCAACGG CCTTTCCCGCGG

           LF                                                                                   F1

CGCCCAGGCCGCTCATG AGGT CG TCCAGACCCTTGAG GTAGGGC GGTAGCGGGTCGA CTACCTT GTCCTCCAC

                          B1                                                     LB                                                                 B2

GTAC TTTACCCGCT GCTT GTACGA GTTGAATTCG CGCATGATCTCTCTTCGAGGTC

                   B3

AAAAACGTTGCTGGAACGCAGCTCTTTCTG-------

 

Text Box: Table 1: Primers targeting glycoprotein B, gB of human cytomegalovirus (HCMV)

Primers  	Primers sequences 	Mm (g/mol)	Tm	Qty (µg)
CMVgB-LB	5’-GCCCTACCTCAAGGGTCTGGA-3’	6407.2	53.1°C	409
CMVgB-LF	5’-GAAGGTGGCAACGCCTTCG-3’	5853.9	62.0°C	395
CMVgB-BIP	5’- CGCCCAGGCCGCTCATGAGGTTTTTAAGGTAGTCGACCCGCTACC-3’	13773.9	69.5°C	936
CMVgB-FIB	5’- AGCCATTGGGGCCGTGGGTGTTTTACGCTCCGAAGGGGTTTTTG-3’	13672.9	67.9 °C	222
CMVgB-B3	5’- AAGCAGCGGGTAAAGTAC-5’	5581.7	54.0°C	360
CMVgB-F3	5’- GGCTATGGCCACGAGGAT-3’	5564.7	58.0°C	149
-----81170
----AGTGATAATGACTACGGCTATGGCCACGAGGATGATGGTG A ACGCTCCGA AGGGGTTTTTG AGGAAGGTG
                                                              F3                                                                               F2
GCAACGCCTTCGA CCACGGA GGC CACCGCG CCACCCACGG CCCCAATGGCT ACGCCAACGG CCTTTCCCGCGG 
           LF                                                                                   F1
CGCCCAGGCCGCTCATG AGGT CG TCCAGACCCTTGAG GTAGGGC GGTAGCGGGTCGA CTACCTT GTCCTCCAC 
                          B1                                                     LB                                                                 B2
GTAC TTTACCCGCT GCTT GTACGA GTTGAATTCG CGCATGATCTCTCTTCGAGGTC 
                   B3 
AAAAACGTTGCTGGAACGCAGCTCTTTCTG-------
https://international.neb.com/protocols/2014/11/21/typical-lamp-protocol-m0275 (Nagamine et al. 2001). In 25 µL of total volume composed of 2.5 µL of 10X Thermopol Buffer containing 2 mM MgSO4 ,1.5 µL of MgSO4 (100 mM),3.5 µL of dNTP Mix (10 mM) 1.4 mM each,1 µL of FIP/BIP Primers (25X) 1 6 µM, 1 µL F3/B3 Primers (25X) 0.2 µM, 1 µL LoopF/B Primers (25X) 0.4 µM, 1 µL Bst DNA Polymerase, Large Fragment (8,000 U/mL) 320 U/mL and 5 µL of DNA extract and 8.5 µm of molecular biology grade water, incubated for 30 to 45 min in a water bath, CMVLAMP products were checked on 1.5% agarose gel.

 

LAMP reaction with bromophenol blue

 

The LAMP reaction was performed in a 25 µL volume composed of 2.5 µL of 10x Thermopol buffer (20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4, 0.1% Triton® X-100, pH 8. 8@25°C),1.5 µL MgSO4 (100 mM), 3.5 µL dNTP Mix (10 mM) 1.4 mM each,1 µL FIP/BIP Primers (25X) 1.6 µM, 1 µL F3/B3 Primers (25X) 0.2 µM, 1 µL LoopF/B primers (25X) 0. 4 µM, 1 µL Bst DNA Polymerase Large Fragment (8,000 U/mL) 320 U/mL, 5 µL of 0.04% Bromophenol Blue as indicator, 5 µL of DNA extract and 3.5 µL of molecular biology grade water, incubated 30–45 min in a water bath, the colorimetric CMVLAMP products were checked by color change following deprotonation during amplification. The protocol is on the link https://international.neb.com/protocols/2014/11/ 21/typical-lamp-protocol-m0275 Accessed on 10/08/2021 (Nagamine et al. 2001).

 

Electrophoresis of LAMP products

 

LAMP products from WarmStart Colorimetric LAMP 2X Master Mix (New England Biolabs, Inc., Ipswich, MA, USA) were detected on the agarose gel for amplification verification. On the 1.5% agarose gel in TBEX1 buffer supplemented with 2.5 µL of ethidium bromide, 10 µL of the LAMP products mixed with 5 µL of green Taq loading buffer were deposited and visualized under ultraviolet.

 

Statistical data analysis

 

All statistical analysis were performed using Microsoft Excel. Normality was tested for all datasets using the D'Agostino Pearson omnibus normality test. Kruskal–Wallis test with Dunn’s correction and Mann–Whitney test were conducted to compare the yield of nucleic acids. Mean values of statistical data and standard deviation curves were calculated using Grubbs Tests. For each protocol, the samples were used with 3 times extractions. Statistically significant values were taken at P < 0.05.

 

Fig. 2: CMV-negative samples remain purple in color after 30 minutes of incubation and CMV-positive samples turn yellow

 

 

Fig. 3: CMV-negative samples remain purple in color after 30 minutes of incubation and CMV-positive samples turn yellow

 

 

Fig. 4: The LAMP method developed in this study can detect an extract containing >10 copies/tube or >150 IU/ml

 

Results

 

Comparison of the results of the methods used in our study

 

To evaluate the reproducibility of the results of the present study, the samples were repeated 3 times and the values presented in the table are the average. These results showed correlation of the methods used as shown in Table 2. We observed 100% positivity and 100% negativity of the correlation between qPCR results, WarmStart Colorimetric LAMP 2X Master Mix and 0.04% Bromophenol Blue.

By using Nanodrop lite, the DNA concentration values showed that amplification of the human Cytomegalovirus specific gene took place. The amplified DNA (A280/A260: 1.77 for amplification with WarmStart and 1.81 for ThermoPol buffer) showed a high purity in comparison with the non-amplified DNA (A280/A260: 2.41) which presents a presence of RNA. It was also noticed that the concentration of DNA is very important in the case of amplified DNA than non-amplified. (Table 3).

 

Positivity and negativity with WarmStart colorimetric LAMP 2X master mix

 

In a water bath, the reaction mixture was incubated with the negative control, the colour change to yellow (which is the proof of positivity) was observed in the samples already positive with qPCR and the negative samples remained purple as shown in (Fig. 2–3).

LAMP reaction sensitivity and specificity with WarmStart colorimetric LAMP 2X master mix

 

The specificity of our method was performed on the plasma of samples tested positive for different viruses such as Herpes Simplex Virus HSV (1-2) Epstein Barr Virus (EBV), Varicella Zona Virus (VZV), these 3 viruses share genetic similarities with Human Cytomegalovirus (HCMV) and BKV of the polyomavirus family and very well known as an opportunistic adenovirus in kidney transplant patients. Our method was able to detect up to 10 copies/µL of HCMV viral load which was the same sensitivity (Fig.4) as the Artus CMV-QS-RGQ kit that we used in this study for comparison. The results show that the LAMP method developed in our study was specific for the HCMV genome and does not cross-react with other viruses (Fig. 5).

Agarose gel of LAMP products/thermopol buffer/WarmStart colorimetric LAMP 2X master mix

 

The protocol was used like normal classic PCR, we have used 2 types of LAMP products, and results with Thermopol buffer on the agarose gel appear as conventional PCR bands (Fig. 6), therefore, LAMP products with WarmStart Colorimetric LAMP 2X Master Mix on the agarose gel appear to have the repeated bands of conventional LAMP (Fig. 7).

Positivity and negativity of 10x ThermoPol buffer and 0.04% bromophenol blue

 

In addition, to evaluate the alternative of the pH indicator, in a CMVLAMP mixture, we used 5 µL of 0.04% bromophenol blue, after 30 min, the positive samples became yellow and the negative samples remained as at the beginning, this is the proof that the amplification has taken place and that the primers are specific. This success is proof of the reliability of the reaction mixture (Fig. 8–9).

Table 2: Table summarizing the correlation of results between the methods used in our study, this method was sensitive to viral load > 150 copies/ml as the results of qPCR used as reference. The sensitivity of this method was 100%, specificity 100%. Each sample was repeated 3 times and the values presented in the table are the average of the 3 values for each part.

 

Samples

HCMV status

[C] ng/µl±SD

Ct (cycle threshold) ±SD

Viral loads (copies/ml)

Viral loads (IU/ml)

Log (IU/ml)

Rouge de phénol (WarmStart)

0.04% Bromophénol Bleu

1

Positive

18.38±0.1979

22.72±1.3410

415838.4

253560

5.404

Positive

Positive

2

Positive

17.23±0.4213

29.14±0.6782

4008.16

2444

3.388

Positive

Positive

3

Positive

20.52±1.3501

24.12±0.9007

111533.12

68008

4.832

Positive

Positive

4

Positive

15.45±1.3797

23.29±1.1617

366002.08

223172

5.348

Positive

Positive

5

Positive

14.35±1.9719

25.78±0.3785

48375.08

29497

4.469

Positive

Positive

6

Positive

18.08±0.0363

23.32±1.1523

209080.156

127487.9

5.105

Positive

Positive

7

Positive

17.08±0.5021

28.35±0.4298

22553.28

13752

4.138

Positive

Positive

8

Positive

19.63±0.8709

26.61±0.1175

34362.92

20953

4.321

Positive

Positive

9

Positive

20.47±1.3232

31.50±1.4205

1064.36

649

2.812

Positive

Positive

10

Positive

19.18±0.6286

28.85±0.5870

77949.2

47530

4.676

Positive

Positive

11

Positive

17.95±0.0337

28.54±0.4895

9065.92

5528

3.742

Positive

Positive

12

Positive

17.83±0.0983

31.85±1.5306

718.894

438,35

2.641

Positive

Positive

13

Positive

18.23±1.1096

23.70±1.0328

242959.44

148146

5.170

Positive

Positive

14

Positive

17.25±0.7439

30.00±0.9487

3989.07

2432.36

3.386

Positive

Positive

15

Négative

12.11±1.1743

N.A

< 150

< 100

N.A

Négative

Négative

16

Négative

15.65±0.1468

N.A

< 150

< 100

N.A

Négative

Négative

17

Négative

16.45±0.4453

N.A

< 150

< 100

 N.A

Négative

Négative

18

Négative

11.85±1.2714

N.A

< 150

< 100

N.A

Négative

Négative

19

Positive

14.23±0.4269

23,64±0.3318

378191.757

230604,730

5.362

Positive

Positive

20

Positive

24.12±1.9999

30,20±1.1748

3592.524

2190,564

3.341

Positive

Positive

21

Positive

15.21±0.1864

31,36±1.4412

1266.129

772,030

2.887

Positive

Positive

22

Positive

11.21±1.1679

25,61±0.1206

52648.408

32102,688

4.506

Positive

Positive

23

Positive

10.56±1.3274

29,81±1.0852

2673.382

1630,111

3.212

Positive

Positive

24

Positive

18.12±0.5276

23,16±0.4420

300137.897

183010,913

5.262

Positive

Positive

25

Positive

15.22±0.1839

31,30±1.4274

926.217

564,767

2.752

Positive

Positive

26

Positive

14.65±0.3238

30,61±1.2689

2159.291

1316,641

3.119

Positive

Positive

27

Positive

17.81±0.4516

25,42±0.0769

107154.579

65338,158

4.815

Positive

Positive

28

Positive

12.11±0.9470

30,73±1.2965

2472.388

1507,554

3.178

Positive

Positive

29

Positive

13.21±0.6771

25,42±0.0769

106746.781

65089,501

4.813

Positive

Positive

30

Positive

19.22±0.7975

26,56±0.3388

47565.925

29003,613

4.462

Positive

Positive

31

Positive

20.11±1.0159

23,41±0.3846

357491.949

217982,896

5.338

Positive

Positive

32

Positive

23.14±1.7594

25,07±0.0034

110679.057

67487,230

4.829

Positive

Positive

34

Positive

18.88±0.7141

21.86±0.7406

140226.21

85503.79

4.931

Positive

Positive

35

Positive

15.55±0.1030

19.03±1.3906

1047440.3

638683.12

5.805

Positive

Positive

36

Positive

12.34±0.8906

18.97±1.4044

10871129.9

662873.76

5.821

Positive

Positive

37

Positive

11.11±1.1924

25.70±0.1412

9162.33

5586.79

3.747

Positive

Positive

38

Positive

21.21±1.2858

13.53±2.6538

51877780.8972

31632793.23

7.500

Positive

Positive

39

Positive

13.54±0.5962

22.27±0.6464

104948.91

63993.24

4.806

Positive

Positive

40

Positive

14.55±0.3483

25.07±0.0034

14395.756

8777.90

3.943

Positive

Positive

41

Positive

12.66±0.8121

23.41±0.3846

46498.1

28352.50

4.452

Positive

Positive

42

Positive

10.30±1.3912

19.33±1.3217

844440.03

514902.46

5.711

Positive

Positive

43

Positive

20.12±1.0184

25.42±0.0769

112142.25

6837.96

3.834

Positive

Positive

44

Positive

16.8±0.2037

23.64±0.3318

39579.64

24133.93

4.382

Positive

Positive

45

Positive

22.64±1.6367

30.20±1.1748

375.97

229.25

2.360

Positive

Positive

46

Positive

12.56±0.8366

26.56±0.3388

49780.01

3035.37

3.482

Positive

Positive

 

Table 3: DNA purity and concentration before and after amplification. S1 and S2 were negative samples while S3 to S7 were positive

 

Samples

without amplification

Amplification with WarmStart

Amplification with 10x Thermopol buffer

A280/A260

[C] ng/µl±SD

A280/A260

[C] ng/µl ±SD

A280/A260

[C] ng/µl ±SD

S1

2.17

47.7 ± 0.212

1.42

45.9 ± 1.427

1.78

57.3 ± 1.468

S2

2.46

75.0 ± 1.905

1.57

60.14 ± 1.416

1.76

72.4 ± 1.457

S3

2.69

46.7 ±0.290

1.78

2484.2 ± 0.466

1.80

2747.3 ± 0.545

S4

2.33

52.4 ± 0.153

1.83

3075 ± 0.925

1.82

2844.7 ± 0.618

S5

2.55

41.2 ± 0.716

1.95

2946.7 ± 0.826

1.89

2820.3 ± 0.599

S6

2.44

39.6 ± 0.840

1.94

2250 ± 0.284

1.84

2715.6 ± 0.521

S7

2.28

41.8 ± 0.606

1.93

2322.4 ± 0.341

1.79

2878.3 ±0.643

 

Discussion

 

Loop-mediated isothermal amplification (LAMP) has been reported to be very efficient, fast and specific (Uwiringiyeyezu et al. 2019, 2022 ; Notomi et al. 2000; Nagamine et al. 2001), these advantages have been improved over time to make this method even more efficient, thus we find studies with the use of 4 to 6 primers, different isothermal enzymes and different types of master mixes, without forgetting the different methods of detection of Text Box:  

Fig. 5: Using the DNA extracts of other viruses of the same family as Cytomegalovirus such as HSV, VZV, BKV and EBV, we concluded the absence of cross-reactions with other viruses which show the specificity of our method

 

Fig. 6: LAMP products with Thermopol buffer on the agarose gel appear as conventional PCR bands. 1: CNT, 2: CMV negative and 3 to 6 CMV+ samples

 

Fig. 7: LAMP products with WarmStart Colorimetric LAMP 2X Master Mix on the agarose gel appear to have the bands of conventional LAMP. 1: CNT, 2 and 3 CMV negative and 4 and 5 CMV+ samples

LAMPPCR products (Nagamine et al. 2001; Nie et al. 2008;

 

Fig. 8: Colorimetric LAMP with 0.04 % bromophenol blue before the reaction

 

 

Fig. 9: Colorimetric LAMP with 0.04% bromophenol blue 30 minutes after the reaction

 

Cai et al. 2008; Suzuki et al. 2006, 2010; Wang et al. 2015; Miyachi et al. 2021). Our study evaluated the viral load of human cytomegalovirus in plasma; the extraction of viral DNA was performed using the EZ1 DSP Virus kit following our validation among other extraction methods that were performed and its availability in our region (Uwiringiyeyezu et al. 2019, 2022).

The purity and concentration of DNA on Nanodrop lite allowed us to validate our choice of sample type; because the quantity is well important and amplifiable by qPCR which is the standard method recommended by the World Health Organization (Lamia et al. 2021). The set of CMVLAMP colorimetric results is evidence of an alternative and potential method in molecular biology. The WarmStart colorimetric LAMP2X Master mix has been shown to be effective in revealing positivity with phenol red, in less than 30 min, this rapidity confirms the role of staining indicator and we obtained the same results using Bromophenol blue (0.04%) in 10x Thermopol buffer (NEB) with a great consistency of the results in the literature reported using other staining indicators such as NeuRed dye (Yuan et al. 2018; Wang et al. 2021), hydroxynaphthol blue (Goto et al. 2009). Cresol red (Gou et al. 2020) Calcein (Suebsing et al. 2015) with the advantage of visualizing the results with the naked eye. Other biological fluids are reported to detect human cytomegalovirus, but their  Table 4: By performing a comparison of the different parameters, CMVLAMP is an alternative method for the detection of HCMV.

 

Comparisons

Real-time PCR

LAMP

Comments

Duration

   > 2hours

30 minutes

LAMP is rapid

Automats

EZ1 Advanced XL, Rotor Q Gene

Heat bloc

 

 

LAMP is cost-effective

Thermocycler

Yes

No

Kits

EZ1 DSP Virus kits

No

Specificity

Specific

Specific

LAMP is also specific than qPCR

Sensitivity

>150  copies/ml

>150 copies/ml

LAMP has same sensitivity than qPCR

Primers

2

6

LAMP is very selective.

Multiplex

Yes

No

LAMP multiplex is very difficult

 

 

viral load is very low compared to the viral load in plasma, such as in urine (Nijman et al. 2012), amniotic fluid (Gouarin et al. 2002), ocular fluid (Reddy et al. 2010) or cerebrospinal fluid and despite the low viral load, these fluids are important to diagnose the pathologies related to them. Blood remains the best medium for viral growth, which explains the high viral loads obtained. Results of qPCR are used for monitoring and treatment of patients, but this method is still expensive due to the use of sophisticated equipment. Our CMVLAMP was cheaper due to the use of routine equipment such as water bath.

 The literature reports that LAMP works well with denatured and non-denatured samples (Notomi et al. 2000; Nagamine et al. 2001). It is reported that as LAMP amplifies, the magnesium pyrophosphate ions form a white precipitate and create a turbidity that can be measured and used as evidence of a positive reaction (Mori et al. 2001). The contribution of the LAMP technique on the diagnosis of Human Cytomegalovirus using the original reaction mixture (Suzuki et al. 2006, 2010; Wang et al. 2015; Roumani et al. 2021) and the results are promising, today, the mixes are pre-prepared and optimized for direct application, so, we tested the WarmStart Colorimetric LAMP 2X Master Mix (DNA & RNA) (NEB, Massachusetts USA, M1800L), thanks to its integrated indicator phenol red and the results confirm those of qPCR. By performing the reaction mixture according to the suppliers, use of 0.04% Bromophenol Blue as a pH indicator also gave interesting results. WarmStart Colorimetric LAMP 2X Master Mix (DNA & RNA) (NEB, Massachusetts USA, M1800L). The success of our study is proof of effectiveness of the WarmStart Colorimetric LAMP 2X Master Mix (DNA & RNA) (NEB, Massachusetts USA, M1800L). The mixing of this master mix is optimized to give results in just 30 min which is the advantage over most other amplification methods. This method encompasses and expands the range of application by its technical simplicity than qPCR and other derivatives. This method has to be evaluated and tested in other types of samples and other methods; it is still difficult to perform multiplex LAMP unlike qPCR. Further research is recommended on this subject to prove that LAMPPCR is an alternative and equivalent method to qPCR with more advantages and simplicity and economic (Table 4).

The literature reports interesting results with the WarmStart Colorimetric LAMP 2X Master Mix on viral infections such as the detection of HPV-16 and HPV-18 DNA with 100% specificity (Daskou et al. 2019), the detection of SARS-COV-2 RNA with the same reliability as RT-qPCR kits (Zhang et al. 2020). Pathogenic bacteria such as Tannerella forsythia and Porphyromonas gingivalis (Al-Hamdoni and Al-Rawi 2020), pathogenic parasites such as Schistosoma japonicum DNA (Rubinfien et al. 2020). Different types of samples such as serum, CSF, urine or nasopharyngeal swabs for the detection of SARS-COV-2.

 

Conclusion

 

LAMP is an alternative method of PCR that encompasses the advantages of speed, reliability, sensitivity and lower cost, this method is performed under isothermal conditions, the use of 4 to 6 primers makes the method faster and very selective. This method has come as a potential answer in different fields of biology and medicine in research and diagnosis. It has minimized the steps of other amplification methods and the reaction mixture is optimized for maximum yield, this makes LAMP, the best method when compared with other invented methods. The overall results of our study prove the advantages of the colorimetric CMVLAMP method in medical diagnosis. To use this method, epidemiological data of pandemics around the world could be recorded directly on site and contribute to the immediate control of the pandemic situation. It is a method that is suitable for any type of samples, type of pathogens or areas remote from laboratories such as forests and does not require the installation of sophisticated equipment. We recommend the use of this method in research on diseases that colonize our daily lives such as HIV, Hepatitis C, tuberculosis, malaria or COVID-19 to standardize it and make it contribute to stop pandemic invasions. This method will provide an economical alternative for medical diagnosis in transplant patients.

 

Acknowledgements

 

We gratefully acknowledge the contribution of all the authors from the Laboratory of Physiopathology, Molecular Biology and Biotechnology-Faculty of Sciences Ain Chock and Laboratory of Medical Analysis AL KINDY-casablanca.

 

Author Contributions

 

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis, and interpretation, or in all these areas; took part in drafting, revising, or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted and decided to be accountable for all aspects of the work.

 

Conflicts of Interest

 

The authors declare no conflict of interest.

 

Data Avaiability

 

The authors confirm that the data supporting the findings of this study are available from the corresponding author on reasonable request.

 

Ethics Approvals

 

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of Hassan II University of Casablanca (2018-321).

 

Informed Consent Statement

 

All subjects gave their informed consent for inclusion before they participated in the study.

 

Consent for Publication

 

All authors reviewed and approved the final version and have agreed to be accountable for all aspects of the work, including any issues related to accuracy or integrity.

 

Limitation of our Study

 

In future studies it is recommended to increase the number of samples, the number of protocols and to vary the different biological fluids and sample volumes.

 

Disclosure

 

The authors declare that they do not have any financial involvement or affiliations with any organization, association, or entity directly or indirectly with the subject matter or materials presented in this article. This also includes honoraria, expert testimony, employment, ownership of stocks or options, patents or grants received or pending, or royalties.

 

References

 

Al-Hamdoni SA, AM Al-Rawi (2020). Colorimetric LAMP molecular method for immediate detection of three periodontal pathogens. Available at: https://assets.researchsquare.com/files/rs-11352/v1/ 72bd83bd-e721-4160-a17d-22c63f3ce937.pdf? c=1631829651

Cai T, G Lou, J Yang, D Xu, Z Meng (2008). Development and evaluation of real-time loop-mediated isothermal amplification for hepatitis B virus DNA quantification: a new tool for HBV management. J Clin Virol 41:270‒276

Da Cunha T, GY Wu (2021). Cytomegalovirus hepatitis in immunocompetent and immunocompromised hosts. J Clin Trans Hepatol 9:106

Daskou M, D Tsakogiannis, TG Dimitriou, GD Amoutzias, D Mossialos, C Kottaridi, P Markoulatos (2019). WarmStart colorimetric LAMP for the specific and rapid detection of HPV16 and HPV18 DNA. J Virol Methods 270:8794

De La Fuente ARIEL, DX Romero Calle, OSCAR Cárdenas Alegría, MT Alvarez Aliaga (2018). Design and Evaluation of primers in silico of the E1 gene of chukungunya virus for Real-Time PCR (q PCR). Revista Con-Ciencia 6:107124

Demmler-Harrison GJ, JA Miller, Houston Congenital Cytomegalovirus Longitudinal Study Group (2020). Maternal cytomegalovirus immune status and hearing loss outcomes in congenital cytomegalovirus-infected offspring. PloS One 15:e0240172

Dourado Junior MET, BFD Sousa, NM Costa, SMB Jeronimo (2021). Cytomegalovirus infection in Guillain-Barré syndrome: A retrospective study in Brazil. Arquivos de Neuro-Psiquiatria 79:607611

Faure-Bardon V, J Fourgeaud, J Stirnemann, M Leruez-Ville, Y Ville (2021). Secondary prevention of congenital CMV infection with valaciclovir following maternal primary infection in early pregnancy. Ultrasound in Obstetrics & Gynecology

Goto M, E Honda, A Ogura, A Nomoto, KI Hanaki (2009). Colorimetric detection of loop-mediated isothermal amplification reaction by using hydroxy naphthol blue. Biotechniques 46:167‒172

Gou H, Z Bian, R Cai, Z Jiang, S Song, Y Li, C Li (2020). The colorimetric isothermal multiple-self-matching-initiated amplification using cresol red for rapid and sensitive detection of porcine circovirus 3. Front Vet Sci 7:407

Gouarin S, E Gault, A Vabret, D Cointe, F Rozenberg, L Grangeot-Keros, F Freymuth (2002). Real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples from mothers with primary infection. J Clin Microbiol 40:1767‒1772

Griffiths P, M Reeves (2021). Pathogenesis of human cytomegalovirus in the immunocompromised host. Nat Rev Microbiol 19:759‒773

Heald-Sargent TA, E Forte, X Liu, EB Thorp, MM Abecassis, ZJ Zhang, MA Hummel (2020). New insights into the molecular mechanisms and immune control of cytomegalovirus reactivation. Transplantation 104:e118

Hollier LM, H Grissom (2005). Human herpes viruses in pregnancy: cytomegalovirus, Epstein-Barr virus, and varicella zoster virus. Clin Perinatolo 32:671‒696

Khalil FO, A Alsebaey, ZA Kasemy, SM Abdelmageed, HM Bedair, S Abdelsattar (2022). IL28B, TLR7 SNPs, and cytomegalovirus infection are risk factors for advanced liver disease in chronic hepatitis C patients. Expert Rev Anti Infect Ther 20:121–129

Lamia D, U Théophile, A Hinde, M Mohamed, B Tarik, S Abdelaziz (2021). Comparison and validation of ichthyoplankton DNA extraction methods. Meth Protoc 4:87

Miyachi M, T ImamuraIchigatani, H Ihara, Y Ohga, M Nishimura, E Sato, S Imafuku (2021). Herpes simplex virus DNA testing by a loopmediated isothermal amplification method for accurate clinical diagnosis and detection of mucosal viral shedding. J Dermatol 49:282288

Mori Y, K Nagamine, N Tomita, T Notomi (2001). Detection of loop-mediated isothermal amplification reaction by turbidity derived from magnesium pyrophosphate formation. Biochem Biophys Res Commun 289:150154

Nagamine K, K Watanabe, K Ohtsuka, T Hase, T Notomi (2001). Loop-mediated isothermal amplification reaction using a nondenatured template. Clin Chem 47:17421743

Nie G, H Dong, G He, X Xu, L Shi, Y Cao, X Chen (2008). The value of loop-mediated isothermal amplification method for rapid diagnosis of EBV DNA. J Clin Otorhinol Head Neck Surg 22:555557

Nijman J, AM Van Loon, LS de Vries, C Koopman-Esseboom, F Groenendaal, CS Uiterwaal, MA Verboon-Maciolek (2012). Urine viral load and correlation with disease severity in infants with congenital or postnatal cytomegalovirus infection. J Clin Virol 54:121‒124

Notomi T, H Okayama, H Masubuchi, T Yonekawa, K Watanabe, N Amino, T Hase (2000). Loop-mediated isothermal amplification of DNA. Nucl Acids Res 28:e63e63

Olbrich L, L Stockdale, R Basu Roy, R Song, L Cicin-Sain, E Whittaker, AJ Prendergast, H Fletcher, JA Seddon (2021). Understanding the interaction between cytomegalovirus and tuberculosis in children: The way forward. PLoS Pathogens 17:e1010061

Pang J, JA Slyker, S Roy, J Bryant, C Atkinson, J Cudini, C Farquhar, P Griffiths, J Kiarie, S Morfopoulou, AC Roxby, H Tutil, R Williams, S Gantt, RA Goldstein, J Breuer (2020). Mixed cytomegalovirus genotypes in HIV-positive mothers show compartmentalization and distinct patterns of transmission to infants. Elife 9:e63199

Reddy AK, PK Balne, RK Reddy, A Mathai, I Kaur (2010). Development and evaluation of loop-mediated isothermal amplification assay for rapid and inexpensive detection of cytomegalovirus DNA in vitreous specimens from suspected cases of viral retinitis. J Clin Microbiol 48:2050‒2052

Roumani F, S Gómez, C Rodrigues, J Barros-Velázquez, A Garrido-Maestu, M Prado (2021). Development and evaluation of a real-time fluorescence, and naked-eye colorimetric, loop-mediated isothermal amplification-based method for the rapid detection of spoilage fungi in fruit preparations. Food Contr 135:108784

Rubinfien J, KD Atabay, NM Nichols, NA Tanner, JA Pezza, MM Gray, BM Wagner, JN Poppin, JT Aken, EJ Gleason, KD Foley, DS Copeland, S Kraves, EA Saavedra (2020). Nucleic acid detection aboard the International Space Station by colorimetric loopmediated isothermal amplification (LAMP). FASEB BioAdvances 2:160165

Rump K, T Rahmel, AM Rustige, M Unterberg, H Nowak, B Koos, P Schenker, R Viebahn, M Adamzik, L Bergmann (2020). The aquaporin 3 promoter polymorphism− 1431 A/G is associated with acute graft rejection and cytomegalovirus infection in kidney recipients due to altered immune cell migration. Cells 9:1421

Suebsing R, J Kampeera, S Sirithammajak, B Withyachumnarnkul, W Turner, W Kiatpathomchai (2015). Colorimetric method of loop-mediated isothermal amplification with the pre-addition of calcein for detecting Flavobacterium columnare and its assessment in tilapia farms. J Aquatic Anim Health 27:38‒44

Suzuki R, M Ihira, Y Enomoto, H Yano, F Maruyama, N Emi, T Yoshikawa (2010). Heat denaturation increases the sensitivity of the cytomegalovirus loopmediated isothermal amplification method. Microbiol Immunol 54:466‒470


Suzuki R, T Yoshikawa, M Ihira, Y Enomoto, S Inagaki, K Matsumoto, Y Asano (2006). Development of the loop-mediated isothermal amplification method for rapid detection of cytomegalovirus DNA. J Virol Meth 132:216‒221

Uchida A, K Tanimura, M Morizane, K Fujioka, I Morioka, M Oohashi, H Yamada (2020). Clinical factors associated with congenital cytomegalovirus infection: A cohort study of pregnant women and newborns. Clin Infectious Dis 71:2833‒2839

Uwiringiyeyezu T, B El Khalfi, J Belhachmi, A Soukri (2019). Loop-mediated isothermal amplification LAMP, simple alternative technique of molecular diagnosis process in medicals analysis: A review. Annl Res Rev Biol 33:1‒12

Uwiringiyeyezu T, B El Khalfi, R Saile, J Belhachmi, A Soukri (2022). Comparability of CMV DNA extraction methods and validation of viral load. Meth Protoc 5:6

Wang X, X Li, S Hu, H Qu, Y Zhang, H Ni, X Wang (2015). Rapid detection of active human cytomegalovirus infection in pregnancy using loop-mediated isothermal amplification. Mol Med Rep 12:2269‒2274

Wang Y, J Dai, Y Liu, J Yang, Q Hou, Y Ou, Y Ding, B Ma, H Chen, M Li, Y Sun, H Zheng, K Zhang, AK Wubshet, AD Zaberezhny, TI Aliper, K Tarasiuk, Z Pejsak, Z Liu, Y Zhang, J Zhang (2021). Development of a potential penside colorimetric LAMP assay using neutral red for detection of African Swine Fever Virus. Front Microbiol 12:516

Winstead RJ, D Kumar, A Brown, I Yakubu, C Song, L Thacker, G Gupta (2021). Letermovir prophylaxis in solid organ transplant—Assessing CMV breakthrough and tacrolimus drug interaction. Transplant Infectious Dis e13570

Yuan D, J Kong, X Li, X Fang, Q Chen (2018). Colorimetric LAMP microfluidic chip for detecting three allergens: peanut, sesame and soybean. Sci Rep 8:1‒8

Zhang Y, N Odiwuor, J Xiong, L Sun, RO Nyaruaba, H Wei, NA Tanner (2020). Rapid molecular detection of SARS-CoV-2 (COVID-19) virus RNA using colorimetric LAMP. MedRxiv

Zheng L, H Li, L Fu, S Liu, Q Yan, SX Leng (2020). Blocking cellular N-glycosylation suppresses human cytomegalovirus entry in human fibroblasts. Microb Pathogen 138:103776